Clincosm LogoSign in Get a demo

Follicular Lymphoma

Showing NaN - NaN of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma Trial in Worldwide (Mosunetuzumab (IV), Tocilizumab, Lenalidomide)

Recruiting
  • Follicular Lymphoma
  • Mosunetuzumab (IV)
  • +3 more
  • Duarte, California
  • +21 more
Jan 10, 2023

Non-Hodgkin Lymphoma, Follicular Lymphoma, DLBCL Trial in Australia, Korea, Republic of, United States (IGM-2323)

Recruiting
  • Non-Hodgkin Lymphoma
  • +4 more
  • Duarte, California
  • +23 more
Dec 28, 2022

Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (tafasitamab, rituximab, lenalidomide)

Recruiting
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • Concord, California
  • +255 more
Dec 1, 2022

Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Worldwide (Betalutin)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Follicular Lymphoma
  • Little Rock, Arkansas
  • +95 more
Sep 9, 2022

Follicular Lymphoma Trial in Worldwide (Idelalisib)

Active, not recruiting
  • Follicular Lymphoma
  • Woodville South, South Australia, Australia
  • +65 more
Aug 24, 2022

Follicular Lymphoma, Marginal Zone Lymphoma Trial in Italy, Spain, United States (EO2463, lenalidomide, rituximab)

Recruiting
  • Follicular Lymphoma
  • Marginal Zone Lymphoma
  • EO2463
  • +2 more
  • Boston, Massachusetts
  • +9 more
Jul 26, 2022

DLBCL, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (Ublituximab, Umbralisib, Bendamustine)

Terminated
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
Jul 20, 2022

Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Marginal Zone Lymphoma Trial in Worldwide (GEN3009, Epcoritamab)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • +7 more
  • GEN3009
  • Epcoritamab
  • Tucson, Arizona
  • +31 more
Jul 1, 2022

DLBCL, Follicular Lymphoma Trial in Worldwide (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, rituximab

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
  • +7 more
  • Birmingham, Alabama
  • +61 more
Apr 13, 2022

DLBCL, Mantle Cell Lymphoma, Follicular Lymphoma Trial in Spain, United States (Loncastuximab Tesirine and Durvalumab)

Terminated
Has Results
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Loncastuximab Tesirine and Durvalumab
  • Birmingham, Alabama
  • +13 more
Sep 28, 2021

Follicular Lymphoma Trial in Worldwide (ibrutinib, to match ibrutinib, rituximab)

Active, not recruiting
  • Follicular Lymphoma
  • Mobile, Alabama
  • +168 more
Oct 6, 2021

Follicular Lymphoma Trial in Worldwide (Rituximab, Lenalidomide, Rituximab - CHOP)

Active, not recruiting
  • Follicular Lymphoma
  • Concord, New South Wales, Australia
  • +34 more
Jul 23, 2021

Follicular Lymphoma Trial in Worldwide (GP2013, rituximab)

Completed
Has Results
  • Follicular Lymphoma
  • GP2013
  • rituximab
  • La Plata, Argentina
  • +152 more
Apr 22, 2021

Follicular Lymphoma Trial in France, Spain, United States (Abexinostat)

Active, not recruiting
  • Follicular Lymphoma
  • Park Ridge, Illinois
  • +14 more
May 10, 2021

Follicular Lymphoma Trial in Worldwide (HCD122)

Completed
  • Follicular Lymphoma
  • Boston, Massachusetts
  • +11 more
Dec 6, 2020

Follicular Lymphoma, Relapsed/Refractory Follicular Lymphoma Trial in Worldwide

Recruiting
  • Follicular Lymphoma
  • Relapsed/Refractory Follicular Lymphoma
    • Split, Croatia
    • +10 more
    Oct 8, 2020

    Follicular Lymphoma Trial in Worldwide (PF-05280586, MabThera®)

    Completed
    Has Results
    • Follicular Lymphoma
    • PF-05280586
    • MabThera®
    • Anaheim, California
    • +422 more
    Jun 18, 2019

    Follicular Lymphoma Trial in Worldwide (Rituximab)

    Completed
    • Follicular Lymphoma
    • Buenos Aires, Argentina
    • +23 more
    Mar 9, 2017